Health Canada inspection
Takeda Pharmaceuticals USA, Inc.: Health Canada inspection of Oct 27, 2023
Health Canada · GMP · rating C
Key facts
| Establishment | Takeda Pharmaceuticals USA, Inc. |
|---|---|
| City | Minneapolis |
| Province | MN |
| Country | United States |
| Program | GMP |
| Start date | Oct 24, 2023 |
| End date | Oct 27, 2023 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.